16:48:48 EDT Tue 05 May 2026
Enter Symbol
or Name
USA
CA



Restart Life Sciences Corp (2)
Symbol HEAL
Shares Issued 59,252,354
Close 2026-05-04 C$ 0.095
Market Cap C$ 5,628,974
Recent Sedar+ Documents

Restart Life Sciences talks up April revenue

2026-05-05 11:14 ET - News Release

Mr. Steve Loutskou reports

RESTART LIFE SCIENCES REPORTS HOLY CRAP FOODS REVENUE GAINS OF 46% IN WHOLESALE AND 32% VIA AMAZON CHANNELS YOY

Restart Life Sciences Corp. has obtained a significant revenue milestone for April, 2026, marking a period of substantial growth following the integration of Holy Crap Foods Inc.

Since completing the acquisition on Feb. 27, 2026, the company has executed a strategic road map focused on stabilizing operations, optimizing channel efficiency and scaling distribution. The April, 2026, financial results demonstrate that these integration efforts have successfully driven strong year-over-year revenue gains.

April, 2026, performance highlights

The company's financial results for April, 2026, significantly outpaced the performance of the same periods in both 2025 and 2024. Total revenue for April, 2026, reached $106,288, representing a 34.2-per-cent increase over April, 2025, revenue of $79,207 and a 33.5-per-cent increase over April, 2024, revenue of $79,595.

Wholesale revenue, which continues to represent the core of the company's Canadian retail distribution network of over 800 locations, demonstrated robust momentum, reaching $87,705. This represents a 45.6-per-cent increase compared with the $60,224 generated in April, 2025, and a 36.4-per-cent increase compared with the $64,282 generated in April, 2024.

Digital and e-commerce acceleration

The company's direct-to-consumer e-commerce channels have demonstrated a notable shift, driven by the continuing testing and refinement of various digital marketing initiatives. This shift is part of an active, continuing testing phase designed to fine-tune channel performance and maximize ROI (return on investment). Marketing efforts and consumer engagement data are being assessed on a daily basis to identify efficiencies, improve conversion metrics, and drive sustained sales growth. Management remains committed to this iterative approach to ensure the brand's digital presence is optimized for long-term scalability.

In addition to broader e-commerce improvements, the company's performance on the Amazon platform has shown significant acceleration. Revenue from Amazon sales for the month of April, 2026, reached $11,000, representing a substantial 145.7-per-cent increase compared with $4,477 in April, 2024, and a notable 32-per-cent gain over the $8,331 recorded in April, 2025. This multiyear growth trend validates the company's specialized strategy to enhance digital brand visibility and consumer education within the Amazon ecosystem.

Strategic outlook

Restart Life Sciences remains focused on scaling brand awareness and improving conversion rates across all platforms. With the foundational integration continuing to progress, the company is continuing its growth-focused strategy in delivering its products to a growing number of households in Canada, continually executing on its growth strategy for the Canadian market while bridging entry into the United States and selected international markets.

"This performance reflects the immediate impact of the strategic initiatives implemented by the Restart Life team postacquisition," said Steve Loutskou, chief executive officer of Restart Life Sciences. "We are seeing strong growth as we continue to test various distribution methods. We believe that over the next few months, we will fine-tune these methods to sustain long-term revenue growth. Seeing total revenue cross the six-figure threshold in April is a strong validation that our focus on gut health, functional nutrition and consumer education is resonating in the marketplace."

Restart Life Sciences thanks its shareholders for their continued support as it advances its strategy and builds out its distribution platform.

About Restart Life Sciences Corp.

Restart Life Sciences is a Canadian-based life sciences company listed on the Canadian Securities Exchange.

About Holy Crap Foods Inc.

Holy Crap Superseed Cereal and Holy Crap Superseed Oatmeal are premium functional food brands offering nutrient-dense, clean-label products made with simple, high-quality ingredients. Based in Gibsons, B.C., the brand has built a loyal and growing customer base across Canada, driven by strong consumer trust and repeat purchases.

Positioned within the fast-growing gut health and wellness category, Holy Crap's gluten-free, non-GMO (genetically modified organism), high-fibre products support digestive health and sustained energy, while gaining traction as a trusted, everyday solution for health-conscious consumers.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.